<DOC>
	<DOC>NCT01943500</DOC>
	<brief_summary>Objective: To test the sensitivity of a proprietary novel filtration device designed to capture and concentrate circulating tumor cells (CTCs).</brief_summary>
	<brief_title>Collection of Blood Specimens for Circulating Tumor Cell Analysis</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplastic Cells, Circulating</mesh_term>
	<criteria>Age &gt; 18 years of age Written informed consent obtained Confirmed diagnosis of stage 24 breast, prostate, or colorectal cancer, (OR) no prior history of cancer Stage 24 treatment naive, metastatic, secondary, and recurrent cancer patients Able to undergo blood collection prior to initiation of chemotherapy treatment, (OR) able to provide blood sample if subject is a noncancer control subject Patients unable to understand the research protocol and/or provide informed consent. Patients with known immunodeficiency, or pregnancy.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>Prostate cancer</keyword>
	<keyword>Colorectal cancer</keyword>
	<keyword>Circulating tumor cell (CTC)</keyword>
</DOC>